Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Long Term Follow Up KET-PD

View source ↗

Summary

An ongoing Yale-sponsored long-term follow-up study (KET-PD) for Parkinson's disease, including depressive symptoms, is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Parkinson's Disease, Depression | Status: ENROLLING_BY_INVITATION